T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
In the murine model of Leishmania major infection, resistance or susceptibility to the parasite has been associated with the development of a Th1 or Th2 type of immune response. Recently, however, the immunosuppressive effects of IL-10 have been ascribed a crucial role in the development of the diff...
Guardado en:
Autores principales: | Tobias Schwarz, Katharina A Remer, Wiebke Nahrendorf, Anita Masic, Lisa Siewe, Werner Müller, Axel Roers, Heidrun Moll |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a045dda4dbae44f1a551cd0e1d5eb9e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NOD1 modulates IL-10 signalling in human dendritic cells
por: Theresa Neuper, et al.
Publicado: (2017) -
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.
por: Ambak K Rai, et al.
Publicado: (2012) -
HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
por: Akil Hammami, et al.
Publicado: (2018) -
Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis.
por: Tej Pratap Singh, et al.
Publicado: (2021) -
Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis
por: Tej Pratap Singh, et al.
Publicado: (2021)